showed a trendp = 0.074
While advanced staging showed a trend toward higher TE incidence in stage III (5, 71.4% vs. 12, 29.2%; p = 0.074), IGCCCG prognostic category emerged as the most significant clinical predictor for TE events, with poor-risk patients showing a significantly higher incidence compared to good or intermediate-risk patients (4, 57.1% vs. 6, 14.6%; p = 0.003).